USE OF RECOMBINANT ONCOLYTIC TYPE II HERPES SIMPLEX VIRUS IN PREPARING MEDICINES AGAINST LYMPHOMA, ESOPHAGEAL CANCER, BREAST CANCER AND PANCREATIC CANCER
The present invention discloses a use of recombinant oncolytic type II herpes simplex virus in preparing medicines against lymphoma, esophageal cancer, breast cancer and pancreatic cancer. The recombinant oncolytic type II herpes simplex virus can specifically grow and reproduce in human tumor cells, without affecting the proliferation of normal cells, thus it can effectively kill cancer cells, presenting good effect. These new indications provide more evidences for drug development and utilization with the recombinant oncolytic type II herpes simplex virus.
